| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0cba269ab40133d9214dd1e7ff036a31 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K127-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00 |
| filingDate |
2020-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2021-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7821e81571ad22d74a7af2a4e1c37797
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9dde8e3ee7e18acfe51bfcae6481f8fd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a93f55e0b2dc6b94e8fd5c5fab8e687d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db3ba442b736642e9736f06586b42933
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b70aa0c19133af744b1fde76b6791f9d |
| publicationDate |
2021-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
RU-2763348-C2 |
| titleOfInvention |
Composition for prevention and treatment of obesity and associated metabolic disorders |
| abstract |
FIELD: pharmaceutics.SUBSTANCE: present invention relates to the pharmaceutical industry, namely to a composition for the prevention and treatment of obesity and associated metabolic disorders. The composition for the prevention and treatment of obesity and associated metabolic disorders includes a dry aqueous extract of large plantain leaves (Plantago major L.), asparaginate of zinc and magnesium in the following weight ratio, wt.%: 50-76 â a dry aqueous extract of large plantain leaves (P. major L.); 20-40 â asparaginate of magnesium (Zn(C4NO4H6)2â
Zn(OH)2); 4-10 â asparaginate of zinc (C8H14MgN4O6).EFFECT: above-described composition is effective relatively to the reduction in fat tissue content in the organism, prevention of obesity-associated disorders in lipid and carbohydrate exchange, as well as development of systematic inflammatory reaction.3 cl, 3 tbl |
| priorityDate |
2020-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |